newsfilter
← Latest News
Business Wire·

For Precision Medicine to Achieve Its Potential, Life Science Leaders Embrace New Data and AI Models

NEW YORK--(BUSINESS WIRE)--Eighty-four percent of senior life science executives agree that precision medicine represents a new era in drug development, according to the Newsweek Vantage report, Precision Medicine: Creating Value for Everyone. Sponsored by Medidata (NASDAQ: MDSO), Thermo Fisher Scientific, and Bristol-Myers Squibb, the survey report highlights the need for data-centric, AI tools and a connected ecosystem in the age of precision medicine.